Lexicon Pharmaceuticals
LXRX
#6179
Rank
โ‚น91.80 B
Marketcap
โ‚น206.67
Share price
-3.14%
Change (1 day)
267.53%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น18.18. In 2024 the company made an earnings per share (EPS) of -โ‚น61.24 an increase over its 2023 EPS that were of -โ‚น76.54.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-73.22%
2024-โ‚น61.24-20%
2023-โ‚น76.5431.15%
2022-โ‚น58.36-0%
2021-โ‚น58.3610.91%
2020-โ‚น52.62-145.08%
2019โ‚น116.73-206.09%
2018-โ‚น110.03-5.74%
2017-โ‚น116.73-10.95%
2016-โ‚น131.082640%
2015-โ‚น4.78-96.34%
2014-โ‚น130.56-2.53%
2013-โ‚น133.95-9.09%
2012-โ‚น147.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,743-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น529.11-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,069-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น584.60 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น602.78-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น47.84 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น71.76 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น133.95-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,340 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA